个性化癌症疫苗：mRNA技术的新希望与挑战

Vaccines based on mRNA can be tailored to target a cancer patient’s unique tumor mutations. But crumbling support for cancer and mRNA vaccine research has endangered this promising therapy BY ROWAN MOORE GERETY ILLUSTRATION BY TAVIS COBURN AS SOON AS BARBARA BRIGHAM’S CANCEROUS PANCREATIC TUMOR WAS removed from her body in the fall of 2020, the buzz of a pager summoned a researcher to the pathology department in Memorial Sloan Kettering’s main hospital in New York City, one floor below. Brigham, then 74, was recovering there until she felt well enough to go home to Shelter Island, near the eastern tip of Long Island. …